2 Recommendations For Biotech Upside
Hated stocks and biotech are the best bets right now.
Stock Market
Upside Potential Over 100% Have Analysts “Pounding The Table” On These 3 Stocks
Among the three stocks highlighted in today’s article where analysts at RBC see upside potential over 100% – and which have all earned “Strong Buy” consensus analyst ratings – is “a pharmaceutical company with a unique niche.
“Explosive Growth Potential”: 2 Under-The-Radar Cancer Drugmakers For Risk-Tolerant Investors
Which developmental-stage biotechs have the potential to beat the difficult odds and successfully get their novel drugs to market?
“The Single Best Investment For The Next Decade”
What is this investment opportunity that seems to check all the boxes?
These 2 Coronavirus Vaccine Stocks Offer “The Best Of Both Worlds”
Of the two “best of both worlds” biotech stocks highlighted in today’s article – “companies with both solid drug-development track records and potential COVID-19 vaccine tailwinds that could net them each significant profits for their role over the next several years”.
How To Play This “Post-Election Bounce” Trend
Today’s article highlights a group of companies that tend to decline before an election – underperforming the stock market by over one-third as we move towards an election – and then recover.
The Case Against These Two Hot COVID-19 Vaccine Stocks
The two biotechs that are the focus of today’s article have been hot this year, with shares of both having experienced triple-digit growth. The reason? Their respective COVID-19 vaccine development programs, which have moved at lightning-fast speed.
“Pour Money Into Your Pocket”: How To Profit From This Soon-To-Be Billion-Dollar Biotech
One billion dollars. Big things happen when a company reaches this threshold in annual sales.
5 Biotech Penny Stocks To Watch Amid An “Unfounded” Time For The Space
“The fact that more than 9 months of this year have been focused on the space is unfounded. In fact, I don’t remember one industry in recent history that has so captivated the stock market as much as this,” says the author of today’s article of the biotech space – and biotech penny stocks in particular.
Unmet Needs And Niche Markets: These Pharma Stocks Have The Momentum
While the surge in interest in pharmaceutical stocks this year has been primarily driven by factors related to the COVID-19 pandemic, the author of today’s article advises that “companies working on pharmaceutical products for unmet needs or other niche markets such as animal health could be worth a closer look.”